Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

MREOMREO
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in MEREO BIOPHARMA GROUP PLC

BANK OF AMERICA CORP /DE/ holds 8.2M shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $2.6M as of 2026-Q2. The position was decreased. MREO represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$2.6M

Current Shares

8.2M

Total Value Change

+$2.6M

Total Shares Change

+8.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8.2M
0.0%
$2.6M0.0%$0.32
0
2026-Q1
Increased
8.2M
+320x
$2.7M0.0%$0.41
42
2025-Q4
Decreased
25,492
-94.2%
$10,6040.0%$0.37
0
2025-Q3
Decreased
438,622
-0.0%
$903,5610.0%$1.96
0
2025-Q2
Decreased
438,661
0.0%
$1.2M0.0%$2.66
0
2025-Q1
Increased
438,670
+188x
$987,0070.0%$2.30
40
2024-Q4
New
2,320
-
$8,1200.0%$3.52
25

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used